Stay updated on Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%
- Check8 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check15 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on disease progression and related attributes. Notably, the version has been updated from v2.16.12 to v3.0.0.SummaryDifference2%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-Surgery in MSI-H Solid Tumors Clinical Trial page.